141 related articles for article (PubMed ID: 10098436)
21. [Radiotherapy only in severe, progressive endocrine orbitopathy: long-term results and comparison of various classification systems].
Gusek-Schneider GC; Seegenschmiedt MH; Jünemann A; Keilholz L; Becker W; Hensen J
Klin Monbl Augenheilkd; 1998 Aug; 213(2):74-80. PubMed ID: 9782464
[TBL] [Abstract][Full Text] [Related]
22. Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study.
Marcocci C; Bartalena L; Panicucci M; Marconcini C; Cartei F; Cavallacci G; Laddaga M; Campobasso G; Baschieri L; Pinchera A
Clin Endocrinol (Oxf); 1987 Jul; 27(1):33-42. PubMed ID: 3308192
[TBL] [Abstract][Full Text] [Related]
23. [Retrobulbar irradiation of endocrine ophthalmopathy: a comparison between 10 and 16 Gy total dose].
Pfluger T; Wendt T; Toroutoglou N; Pickardt C; Wuttge R
Strahlenther Onkol; 1990 Oct; 166(10):673-7. PubMed ID: 2237752
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy in the management of Graves' ophthalmopathy.
Sakata K; Hareyama M; Oouchi A; Shidou M; Nagakura H; Morita K; Osanai H; Ohtsuka K; Hinoda Y
Jpn J Clin Oncol; 1998 Jun; 28(6):364-7. PubMed ID: 9730150
[TBL] [Abstract][Full Text] [Related]
25. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
26. Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy.
Elbers L; Mourits M; Wiersinga W
Thyroid; 2011 Mar; 21(3):279-83. PubMed ID: 21190446
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L
J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of Graves' ophthalmopathy with irradiation].
Slampa P; Spurný V; Seneklová Z; Krákorová D
Vnitr Lek; 1998 Aug; 44(8):461-3. PubMed ID: 10358449
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
[TBL] [Abstract][Full Text] [Related]
31. An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy.
Teng CS; Crombie AL; Hall R; Ross WM
Clin Endocrinol (Oxf); 1980 Dec; 13(6):545-51. PubMed ID: 6784979
[TBL] [Abstract][Full Text] [Related]
32. Orbital radiotherapy for Graves' ophthalmopathy.
Bartalena L; Marcocci C; Tanda ML; Rocchi R; Mazzi B; Barbesino G; Pinchera A
Thyroid; 2002 Mar; 12(3):245-50. PubMed ID: 11952048
[TBL] [Abstract][Full Text] [Related]
33. Graves' ophthalmopathy: natural history and treatment outcomes.
Noth D; Gebauer M; Müller B; Bürgi U; Diem P
Swiss Med Wkly; 2001 Oct; 131(41-42):603-9. PubMed ID: 11820071
[TBL] [Abstract][Full Text] [Related]
34. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
[TBL] [Abstract][Full Text] [Related]
35. Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy.
Fatourechi V; Bergstralh EJ; Garrity JA; Bartley GB; Beatty CW; Offord KP; Gorman CA
Mayo Clin Proc; 1994 Sep; 69(9):841-8. PubMed ID: 8065185
[TBL] [Abstract][Full Text] [Related]
36. Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy.
Pinchera A; Marcocci C; Bartalena L; Panicucci M; Marconcini C; Lepri A; Cavallacci G; Cartei F; Laddaga M
Horm Res; 1987; 26(1-4):177-83. PubMed ID: 3596466
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy for moderate-to-severe Graves' ophthalmopathy: improved outcomes with early treatment.
Alpert TE; Alpert SG; Bersani TA; Hahn SS; Bogart JA; Chung CT
Cancer J; 2003; 9(6):472-5. PubMed ID: 14740976
[TBL] [Abstract][Full Text] [Related]
38. A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy.
Schaefer U; Hesselmann S; Micke O; Schueller P; Bruns F; Palma C; Willich N
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):192-7. PubMed ID: 11777638
[TBL] [Abstract][Full Text] [Related]
39. Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves' disease for evaluation of active inflammation.
Uslu-Beşli L; Kabasakal L; Sağer S; Cicik E; Asa S; Sönmezoğlu K
Nucl Med Commun; 2017 Nov; 38(11):964-970. PubMed ID: 28863123
[TBL] [Abstract][Full Text] [Related]
40. Treatment of acute Graves orbitopathy.
Kazim M; Trokel S; Moore S
Ophthalmology; 1991 Sep; 98(9):1443-8. PubMed ID: 1945322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]